Defence And Security Tenders

Medicines Containing the Active Ingredient Fulvestrant (Atc: L02ba03)

Open House Drug Discount Contracts Ibuprofen, Prescription, in Immediate-Release Dosage Form with the Potency 400Mg and 600Mg, Atc M01ae01

Open House Drug Discount Agreements Cinacalcet, Atc H05bx01

Open House Drug Discount Agreements Certolizumab Pegol, Atc L04ab05

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Metoprolol and Hydrochlorothiazide (C07bb22) as Part of a House Model.

General Acquisition Notice (aga) - Br -l1589

Open House Drug Discount Agreements Glatiramer Acetate, in Pre-Filled Pen Dosage Form, Atc L03ax13

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Valproic Acid (N03ag01) as Part of a So-Called Open House Model.

Drugs Containing the Active Ingredient Cinacalcet (Atc: H05bx01)